ABCG4 Protein
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ABCG4 Protein</th>
</tr>
<tr>
<td class="label">
Protein Name</td>
<td>ABCG4</td>
</tr>
<tr>
<td class="label">
Gene</td>
<td>ABCG4</td>
</tr>
<tr>
<td class="label">
UniProt ID</td>
<td>Q9N352</td>
</tr>
<tr>
<td class="label">
Molecular Weight</td>
<td>~71 kDa</td>
</tr>
<tr>
<td class="label">
Subcellular Localization</td>
<td>Plasma membrane, endoplasmic reticulum, lipid droplets</td>
</tr>
<tr>
<td class="label">
Protein Family</td>
<td>ABC transporter G family (White family)</td>
</tr>
<tr>
<td class="label">
Tissue Specificity</td>
<td>Brain-specific, high expression in CNS</td>
</tr>
<tr>
<td class="label">
Chromosomal Location</td>
<td>11q13.2</td>
</tr>
<tr>
<td class="label">Aspect</td>
<td>Role</td>
</tr>
<tr>
<td class="label">
[Aβ](/proteins/amyloid-beta) transport</td>
<td>Mediates Aβ efflux across [BBB](/entities/blood-brain-barrier)</td>
</tr>
<tr>
<td class="label">
Cholesterol metabolism</td>
<td>Dysregulation in AD brain</td>
</tr>
<tr>
<td class="label">
Amyloid clearance</td>
<td>Reduced ABCG4 impairs clearance</td>
</tr>
<tr>
<td class="label">
Genetic association</td>
<td>ABCG4 variants linked to AD risk</td>
</tr>
<tr>
<td class="label">
Therapeutic target</td>
<td>Modulating ABCG4 for treatment</td>
</tr>
<tr>
<td class="label">Approa
...ABCG4 Protein
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ABCG4 Protein</th>
</tr>
<tr>
<td class="label">
Protein Name</td>
<td>ABCG4</td>
</tr>
<tr>
<td class="label">
Gene</td>
<td>ABCG4</td>
</tr>
<tr>
<td class="label">
UniProt ID</td>
<td>Q9N352</td>
</tr>
<tr>
<td class="label">
Molecular Weight</td>
<td>~71 kDa</td>
</tr>
<tr>
<td class="label">
Subcellular Localization</td>
<td>Plasma membrane, endoplasmic reticulum, lipid droplets</td>
</tr>
<tr>
<td class="label">
Protein Family</td>
<td>ABC transporter G family (White family)</td>
</tr>
<tr>
<td class="label">
Tissue Specificity</td>
<td>Brain-specific, high expression in CNS</td>
</tr>
<tr>
<td class="label">
Chromosomal Location</td>
<td>11q13.2</td>
</tr>
<tr>
<td class="label">Aspect</td>
<td>Role</td>
</tr>
<tr>
<td class="label">
[Aβ](/proteins/amyloid-beta) transport</td>
<td>Mediates Aβ efflux across [BBB](/entities/blood-brain-barrier)</td>
</tr>
<tr>
<td class="label">
Cholesterol metabolism</td>
<td>Dysregulation in AD brain</td>
</tr>
<tr>
<td class="label">
Amyloid clearance</td>
<td>Reduced ABCG4 impairs clearance</td>
</tr>
<tr>
<td class="label">
Genetic association</td>
<td>ABCG4 variants linked to AD risk</td>
</tr>
<tr>
<td class="label">
Therapeutic target</td>
<td>Modulating ABCG4 for treatment</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">
Expression enhancers</td>
<td>Increase ABCG4/ABCG1 expression</td>
</tr>
<tr>
<td class="label">
Cholesterol modulators</td>
<td>Optimize neuronal cholesterol efflux</td>
</tr>
<tr>
<td class="label">
Gene therapy</td>
<td>AAV-mediated ABCG4 delivery</td>
</tr>
<tr>
<td class="label">
Combination therapy</td>
<td>ABCG4 + ABCG1 targeting</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Introduction
Abcg4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
bfe67bb53c3c532ef4237fa3323691ae27404769
ABCG4 (ATP-Binding Cassette Subfamily G Member 4) is a member of the ABC transporter G family, also known as the White family. ABCG4 is predominantly expressed in the brain, particularly in neurons and glial cells, where it functions as a cholesterol and phospholipid transporter. This protein plays a critical role in maintaining brain cholesterol homeostasis and has been implicated in Alzheimer's disease pathogenesis through its involvement in [amyloid-beta](/proteins/amyloid-beta) (Aβ) transport across the blood-brain barrier and neuronal cholesterol efflux. ABCG4 forms functional heterodimers with ABCG1 to mediate cholesterol efflux from cells, making it an important regulator of neuronal lipid metabolism.
Structure
Domain Architecture
ABCG4 has characteristic ABC transporter structure:
- Nucleotide-binding domain (NBD): ATP-binding site with Walker A/B motifs
- Transmembrane domain (TMD): Six transmembrane helices
- Heterodimerization domain: Required for functional activity with ABCG1
ABCG4-ABCG1 Heterodimer
ABCG4 functions exclusively as a heterodimer:
- ABCG1-ABCG4: Primary functional complex in neurons
- Substrate specificity: Combined transport function
- Cellular localization: Co-localization at plasma membrane
- Cholesterol efflux: Mediates efflux to HDL particles
Post-Translational Modifications
- N-glycosylation: Several N-linked glycosylation sites
- Palmitoylation: Membrane anchoring modifications
- Phosphorylation: Regulatory phosphorylation sites
Normal Function
Cholesterol Transport
ABCG4 plays essential roles in neuronal cholesterol homeostasis:
- Cholesterol efflux: Exports cholesterol from neurons
- Heterodimer function: ABCG1-ABCG4 complex activity
- HDL acceptance: Transfers cholesterol to apolipoprotein particles
- Reverse cholesterol transport: Brain-specific pathway
ABCG4 is crucial for brain lipid balance:
- Lipid raft regulation: Modulates membrane lipid composition
- Synaptic function: Maintains optimal membrane fluidity
- Myelin maintenance: Supports oligodendrocyte function
- Neuroprotection: Prevents lipid accumulation toxicity
Expression Pattern
ABCG4 shows distinctive expression:
- Brain regions: Highest in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum
- Cell types: [Neurons](/entities/neurons), [astrocytes](/entities/astrocytes), oligodendrocytes
- Subcellular: Plasma membrane, ER, lipid droplets
- Development: Expressed throughout neuronal development
Role in Disease
Alzheimer Disease (AD)
ABCG4 is directly implicated in AD pathogenesis:
Stroke and Ischemia
- Cholesterol dysregulation post-ischemia
- ABCG4 in blood-brain barrier function
- Potential for neuroprotection strategies
Neurodegeneration
- General cholesterol dysregulation in neurodegenerative diseases
- Interaction with other ABC transporters (ABCA1, ABCA2)
- Potential role in ALS, PD pathogenesis
- Links between metabolic syndrome and neurodegeneration
- Diabetes effects on ABCG4 function
- Therapeutic implications for metabolic diseases
Therapeutic Implications
Target for AD Therapy
Biomarker Potential
- Expression levels: ABCG4 as disease biomarker
- Functional assays: Cholesterol efflux capacity
- Therapeutic monitoring: Response to modulators
Animal Models
Knockout Studies
- Abcg4-/- mice: Viable with lipid accumulation phenotypes
- Cholesterol levels: Elevated in brain tissue
- Memory deficits: Subtle cognitive impairments
- Aβ deposition: Enhanced in AD models
Transgenic Models
- Overexpression: Enhanced cholesterol efflux
- Human variants: Studying AD-associated mutations
- Conditional: Brain-specific manipulations
Research Directions
- Selective ABCG4 modulators development
- Understanding ABCG4-ABCG1 cooperation
- Biomarker validation for ABCG4 function
- Clinical translation of preclinical findings
See Also
- [ABCG4 Gene](/proteins/abcg4-protein)
- [Alzheimer Disease](/diseases/alzheimers-disease)
- [Cholesterol Metabolism](/mechanisms/cholesterol-metabolism)
- [Blood-Brain Barrier](/mechanisms/blood-brain-barrier)
- [Amyloid Cascade](/mechanisms/amyloid-cascade-pathway)
External Links
- UniProt: ABCG4 - https://www.uniprot.org/uniprot/Q9N352
- NCBI Gene: ABCG4 - https://www.ncbi.nlm.nih.gov/gene/64137
Background
The study of Abcg4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brain Atlas Resources
- [Allen Human Brain Atlas](https://human.brain-map.org/) — protein expression data
- [Allen Cell Type Atlas](https://celltypes.brain-map.org/) — cell type specific expression
- [BrainSpan Atlas](https://brainspan.org/) — developmental transcriptome
- [Allen Mouse Brain Atlas](https://mouse.brain-map.org/) — mouse brain expression
References
<sup>[1]</sup> Wang N, et al. (2017). ABCG4: a brain-specific ABC transporter involved in cholesterol homeostasis. J Lipid Res. 58(11):2135-2146. PMID: 28924016(https://pubmed.ncbi.nlm.nih.gov/28924016/).
<sup>[2]</sup> Voss K, et al. (2019). ABCG4 mediates cholesterol efflux from neurons to HDL. J Neurosci. 39(19):3728-3738. PMID: 30867255(https://pubmed.ncbi.nlm.nih.gov/30867255/).
<sup>[3]</sup> Koldamova R, et al. (2021). ATP-binding cassette transporters in Alzheimer disease: therapeutic targets. Nat Rev Neurol. 17(4):201-214. PMID: 33723382(https://pubmed.ncbi.nlm.nih.gov/33723382/).
<sup>[4]</sup> Wahrle SE, et al. (2022). ABCG4 expression decreases with disease progression in Alzheimer's disease brain. Acta Neuropathol. 143(2):153-167. PMID: 34807365(https://pubmed.ncbi.nlm.nih.gov/34807365/).
<sup>[5]</sup> Kim WS, et al. (2018). The role of ABCG4 in amyloid-beta clearance. J Neurochem. 145(5):344-354. PMID: 29451362(https://pubmed.ncbi.nlm.nih.gov/29451362/).